Description

Ethanone, 1-(4-Bromophenyl)-2-[[5-(4-Pyridinyl)-1,3,4-Oxadiazol-2-Yl]Thio]- is a high-purity, advanced pharmaceutical intermediate featuring a unique heterocyclic structure. This compound is specifically engineered for applications requiring precise molecular architecture, offering a critical building block for the synthesis of novel active pharmaceutical ingredients (APIs). It is primarily utilized by research institutions and pharmaceutical manufacturers engaged in the development of new therapeutic agents, particularly in areas such as oncology and antiviral research.

Application

• Pharmaceutical Intermediate: Serves as a key precursor in the multi-step synthesis of complex drug candidates, especially those targeting specific enzyme inhibition.
• Research & Development (R&D): Used in medicinal chemistry for structure-activity relationship (SAR) studies and the discovery of new bioactive molecules.
• Chemical Biology Probes: Acts as a scaffold for developing probes to study biological pathways and protein interactions due to its oxadiazole and pyridine motifs.
• Agrochemical Research: Potential application in the synthesis of novel herbicides or pesticides, leveraging its heterocyclic core.
• Material Science: Investigated as a monomer or additive for creating specialized polymers with specific electronic or thermal properties.

Basic Information

Product Name	Ethanone, 1-(4-Bromophenyl)-2-[[5-(4-Pyridinyl)-1,3,4-Oxadiazol-2-Yl]Thio]-
CAS No.	491839-65-7
Molecular Formula	C15H10BrN3O2S
Molecular Weight	376.23 g/mol
Synonyms	1-(4-Bromophenyl)-2-{[5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl]sulfanyl}ethanone; 2-[(1-(4-Bromophenyl)-2-oxoethyl)thio]-5-(4-pyridinyl)-1,3,4-oxadiazole; 4-Bromophenyl {[5-(4-pyridinyl)-1,3,4-oxadiazol-2-yl]thio}methyl ketone; (4-Bromophenyl){[5-(4-pyridinyl)-1,3,4-oxadiazol-2-yl]sulfanyl}methanone; CAS 491839-65-7
EINECS	Contact for details

Quality Control

Our Ethanone, 1-(4-Bromophenyl)-2-[[5-(4-Pyridinyl)-1,3,4-Oxadiazol-2-Yl]Thio]- is manufactured under a strict quality management system. Every batch undergoes rigorous analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all critical specifications. Our quality commitment aligns with cGMP principles for pharmaceutical intermediates, ensuring reliability for your most demanding R&D and scale-up processes.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Keep away from heat, sparks, and open flame. For long-term storage, consider storing under an inert atmosphere to maximize stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.